BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25298407)

  • 1. The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma.
    Bianchi-Frias D; Hernandez SA; Coleman R; Wu H; Nelson PS
    Mol Cancer Res; 2015 Feb; 13(2):339-47. PubMed ID: 25298407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.
    Bianchi-Frias D; Basom R; Delrow JJ; Coleman IM; Dakhova O; Qu X; Fang M; Franco OE; Ericson NG; Bielas JH; Hayward SW; True L; Morrissey C; Brown L; Bhowmick NA; Rowley D; Ittmann M; Nelson PS
    Mol Cancer Res; 2016 Apr; 14(4):374-84. PubMed ID: 26753621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.
    Zimonjic DB; Ullmannova-Benson V; Factor VM; Thorgeirsson SS; Popescu NC
    Cancer Genet Cytogenet; 2009 May; 191(1):17-26. PubMed ID: 19389504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
    Van Dekken H; Krijtenburg PJ; Alers JC
    Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling.
    Wanjala J; Taylor BS; Chapinski C; Hieronymus H; Wongvipat J; Chen Y; Nanjangud GJ; Schultz N; Xie Y; Liu S; Lu W; Yang Q; Sander C; Chen Z; Sawyers CL; Carver BS
    Mol Cancer Ther; 2015 Jan; 14(1):278-88. PubMed ID: 25381262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
    Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
    Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data.
    Williams JL; Greer PA; Squire JA
    Cancer Genet; 2014; 207(10-12):474-88. PubMed ID: 25434580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal changes during development and progression of prostate adenocarcinomas.
    Zitzelsberger H; Engert D; Walch A; Kulka U; Aubele M; Höfler H; Bauchinger M; Werner M
    Br J Cancer; 2001 Jan; 84(2):202-8. PubMed ID: 11161378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer.
    Sattler HP; Rohde V; Bonkhoff H; Zwergel T; Wullich B
    Prostate; 1999 May; 39(2):79-86. PubMed ID: 10221562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.
    Kim J; Roh M; Doubinskaia I; Algarroba GN; Eltoum IE; Abdulkadir SA
    Oncogene; 2012 Jan; 31(3):322-32. PubMed ID: 21685943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.
    Heselmeyer-Haddad KM; Berroa Garcia LY; Bradley A; Hernandez L; Hu Y; Habermann JK; Dumke C; Thorns C; Perner S; Pestova E; Burke C; Chowdhury SA; Schwartz R; Schäffer AA; Paris PL; Ried T
    Am J Pathol; 2014 Oct; 184(10):2671-86. PubMed ID: 25131421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
    Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH
    BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas.
    Ribeiro FR; Henrique R; Hektoen M; Berg M; Jerónimo C; Teixeira MR; Lothe RA
    Mol Cancer; 2006 Sep; 5():33. PubMed ID: 16952311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin is epigenetically regulated in prostate cancer.
    Rauhala HE; Porkka KP; Saramäki OR; Tammela TL; Visakorpi T
    Int J Cancer; 2008 Oct; 123(7):1601-9. PubMed ID: 18649357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal changes in incidental prostatic carcinomas detected by comparative genomic hybridization.
    Wolter H; Trijic D; Gottfried HW; Mattfeldt T
    Eur Urol; 2002 Mar; 41(3):328-34. PubMed ID: 12180237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.